Australia markets closed

Gamida Cell Ltd. (GMDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.2000-0.0800 (-3.51%)
At close: 04:00PM EDT
2.8000 +0.60 (+27.27%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.2800
Open2.3600
Bid2.2100 x 1000
Ask2.5000 x 1000
Day's range2.1700 - 2.3600
52-week range2.1000 - 6.8400
Volume362,166
Avg. volume736,185
Market cap131.882M
Beta (5Y monthly)1.81
PE ratio (TTM)N/A
EPS (TTM)-1.5310
Earnings date10 May 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.83
  • Business Wire

    Gamida Cell to Present Corporate Highlights at the H.C. Wainwright Global Life Sciences Conference

    BOSTON, May 17, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced that company management will present at the upcoming H.C. Wainwright Global Life Sciences Conference. A pre-recorded presentation will become available to registered conference attendees on May 24, 2022 at 7:00 a.m. ET. Management will discuss 2022 catalysts and potential milestones including

  • Business Wire

    Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update

    BOSTON, May 10, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today provided a business update and reported financial results for the quarter ended March 31, 2022. Net loss for the first quarter of 2022 was $20.2 million, compared to a net loss of $19.2 million in the first quarter of 2021. As of March 31, 2022, Gamida Cell had total cash and cash equivalents of $69.7

  • Simply Wall St.

    Gamida Cell Ltd. (NASDAQ:GMDA): When Will It Breakeven?

    With the business potentially at an important milestone, we thought we'd take a closer look at Gamida Cell Ltd.'s...